Bozic Carmen 4

What Happened
Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), had 3,804 shares disposed to satisfy an exercise price or tax liability (transaction code F). The shares were valued at $487.76 each, totaling $1,855,439. This was a tax-withholding/net settlement related to equity compensation, not an open-market sale.

Key Details

• Transaction date: 2026-02-13
• Action: Payment of exercise price or tax liability (code F) — 3,804 shares withheld/disposed
• Price used: $487.76 per share; total value $1,855,439
• Shares owned after transaction: not specified in the filing
• Filing date: 2026-02-18 — filed within the two-business-day window (Feb 16 was a U.S. holiday), so the Form 4 appears timely
• Note: Code F indicates shares were used to cover tax or exercise obligations (net settlement/cashless withholding), a routine administrative transaction

Context
Withholding shares to cover taxes is common when executives exercise options or vest restricted stock; it is not the same as a market sale and generally should not be interpreted as a directional bet on the stock. Purchases by insiders tend to be more informative about confidence than routine tax-withholding disposals.